CASP3 and hepatocellular carcinoma: Earlier studies on the antitumor effect of MSCs of bone marrow origin on mouse hepatoma cells documented that MSCs could induce inhibitory effects on tumor cells via upregulation of mRNA expression of cell cycle negative regulator p21 and pro-apoptotic protease caspase 3, leading to apoptotic death of cancer cells [48].